semaglutide off patent A major shift in India’s pharma landscape., is now off-patent, opening doors for affordable access., But with opportunity comes responsibility., This isn’t just another generic., It’s a Semaglutide: Just Another Off-Patent Generic?

AllegaertKSmitsAvan den AnkerJN

(Detailed Explanation) Intermittent fasting (IF) is not a diet in the traditional senseit is an eating schedule

CrossRef Validation and Comparison of PROMISE and CONFIRM Model to Predict High-Risk Coronary Artery Disease in Symptomatic and Diabetes Mellitus Patients Hantao Jiang, Jinping Feng, Chao Feng, Pei Ren, Kai Ren, Ying Jin, Jia Zhou Reviews in Cardiovascular Medicine.2022;[Epub] CrossRef The prevalence of cardiac autonomic neuropathy in prediabetes: a systematic review Aikaterini Eleftheriadou, Scott Williams, Sarah Nevitt, Emily Brown, Rebecca Roylance, John P

The cost-effectiveness of once-weekly semaglutide compared with other GLP-1 receptor agonists in type 2 Diabetes: a systematic literature review